Login
$URGN
$27.54 -$0.56 (1.99%) After hours

$URGN SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13G/A
04 Nov 2026 FORM S-8
04 Nov 2026 FORM 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition

ZUSDURI® generated $68.0 million in revenue in the third quarter of 2026, representing 35% quarter-over-quarter growth

27 Oct 2026 SCHEDULE 13G/A
09 Oct 2026 Form 4: Degnan Chris, Chief Financial Officer

Received 4,483 shares by exercise or conversion · Sold 2,202 shares ($80.8K)

09 Oct 2026 144
09 Sep 2026 Form 4: Schoenberg Mark, Chief Medical Officer

Received 1,667 shares by exercise or conversion · Sold 871 shares ($37.4K)

09 Sep 2026 Form 4: Smith Jason Drew, General Counsel

Received 3,334 shares by exercise or conversion · Sold 1,519 shares ($64.6K)

09 Sep 2026 144
09 Sep 2026 144
28 Aug 2026 Form 4: Robinson James A. Jr., Director

Received 2,000 shares by exercise or conversion

24 Aug 2026 Form 4: Schoenberg Mark, Chief Medical Officer

Sold 60,677 shares ($2.85M)

20 Aug 2026 144
20 Aug 2026 8-K: Other Events

On August 18, 2026, UroGen Pharma Ltd. (“the Company”), through its wholly owned subsidiary UroGen Pharma, Inc. (“UroGen U.S.”), entered into an Option and Research License Agreement (the “Option Agreement”) with IntraGel Therapeutics, L...

12 Aug 2026 SCHEDULE 13G/A
05 Aug 2026 FORM 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition

ZUSDURI® generated $50.4 million in revenue in the second quarter of 2026, representing 73% quarter-over-quarter growth

10 Jul 2026 Form 4: Schoenberg Mark, Chief Medical Officer

Sold 10,000 shares ($400K)

09 Jul 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support